RENAISSANCE TECHNOLOGIES LLC

Position in YARW — Yarrow Bioscience, Inc.

CIK 1037389 NEW YORK, NY

Position in YARW

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$10,345

-$7,050 QoQ

Shares Held

17,300

+64.1% QoQ

Ownership

0.052%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

RENAISSANCE TECHNOLOGIES LLC holds $3,450,872,574 across 330 Biotechnology names. YARW ranks #326 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	13,726,993	$588,750,729
2	INCY	Incyte Corp	3,651,532	$343,682,191
3	CORT	Corcept Therapeutics Inc	5,682,783	$229,072,982
4	VRTX	Vertex Pharmaceuticals Inc / Ma	421,688	$188,300,559
5	JAZZ	Jazz Pharmaceuticals plc	819,374	$154,902,654
6	GMAB	Genmab A/S	4,414,550	$118,442,376
7	INVA	Innoviva, Inc.	4,055,632	$94,496,225
8	ARWR	Arrowhead Pharmaceuticals, Inc.	1,036,495	$64,988,236

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$10,345	17,300	+64.1%	Shares	Sole	2026-05-14
2025-06-30	$17,395	10,543	-90.8%	Shares	Sole	2025-08-13
2025-03-31	$181,925	115,143	+361.6%	Shares	Sole	2025-05-14
2024-12-31	$83,559	24,943	-71.2%	Shares	Sole	2025-02-13
2024-09-30	$162,888	86,643	+37.3%	Shares	Sole	2024-11-13
2024-06-30	$124,328	63,111	-21.7%	Shares	Sole	2024-08-09
2024-03-31	$247,368	80,576	+73.7%	Shares	Sole	2024-05-13
2023-12-31	$108,056	46,376	+78.5%	Shares	Sole	2024-02-13
2023-09-30	$104,943	25,976	-28.0%	Shares	Sole	2023-11-14
2023-06-30	$147,911	36,076	+41.0%	Shares	Sole	2023-08-11
2023-03-31	$78,789	25,581	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.